Viewing Study NCT04163302

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:01 AM
Ignite Modification Date: 2026-02-03 @ 8:58 AM
Study NCT ID: NCT04163302
Status: UNKNOWN
Last Update Posted: 2019-11-15
First Post: 2019-11-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Efficiency Study of CD19-PD1-CART Cell in Relapsed/Refractory B Cell Lymphoma
Sponsor: Chinese PLA General Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, B-Cell View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lymphoma View
None Chimeric antigen receptor T cell View
None Chimeric antigen receptor View
None Immunotherapy View
None PD-1 View
None CD19 View